Trending...
- Spokane: Chat & Chew District 3 Council Members
- CAPHRA: Australia and Thailand show nicotine prohibition fuels illicit markets
- Brilliant Minds to Gather in Fort Worth for National Mensa Event
SEATTLE, April 9, 2021 /PRNewswire/ -- Today, FidaLab, a CLIA-certified clinical diagnostic company based in Seattle announced its partnership with Concentric by Ginkgo to provide a scalable and simple testing modality - pooled testing - to serve K-12 schools.
As more and more schools work to support in-person learning environments, communities across the country have turned to COVID-19 testing to monitor the virus. Even as teachers and guardians become eligible for vaccines, clinical vaccine trials for individuals under 16 are just beginning, and efforts to track and mitigate viral spread remain critical.
Concentric by Ginkgo's goal is to provide easy, affordable pooled testing to every school in America. Pooled classroom testing, which combines swabs from all consenting individuals in a classroom and runs them as a single test can significantly increase testing capacity and lower the cost of testing programs. Over 800 hundred schools are currently signed up to test with Concentric across the country.
"We are excited at the prospect of joining Ginkgo to provide mass COVID testing in schools to help maintain in-person learning environments in Washington. Ginkgo has proven itself in successfully implementing school testing programs in the State of Massachusetts, Maryland, and beyond. The combination of our local testing capability and Ginkgo's experience and organizational strength will provide a very reliable option for Washington school systems," said Myles Yu, Chief Medical Officer of FidaLab.
More on Washingtoner
On February 17, 2021, the U.S. Department of Health and Human Services (HHS) in partner with the Department of Defense (DOD) has announced a $650 million investment to expand COVID-19 testing capacity for K-8 schools to support President Biden's plan to re-open schools for in-person learning.
"The funding provided by the Biden Administration will help make it possible for schools in Washington and across the country to engage in pooled testing for every student, every week," said Jason Kelly, CEO and co-founder of Ginkgo Bioworks. "Testing in schools will support the entire community by providing opportunities to limit the spread, and to interrupt chains of transmission."
FidaLab joined the fight against the COVID-19 pandemic at the very beginning and has built massive PCR testing capability for SARS-CoV-2, the virus that causes COVID-19. FidaLab has provided mass testing in collaboration with large scale county testing, schools, long term care facilities, athletic teams and more.
To learn more about Concentric by Ginkgo or to get your school district involved, head over to concentricbyginkgo.com.
About FidaLab
FidaLab is a privately owned CLIA-certified clinical laboratory based in Seattle with a specialty in molecular diagnosis of infectious diseases using cutting edge biotechnologies. With its proven diagnostic accuracy and 24-hour turnaround time, FidaLab has earned the trust of the communities it serves.
More on Washingtoner
About Ginkgo Bioworks
Concentric by Ginkgo is Ginkgo Bioworks' public health and biosecurity effort. Headquartered in Boston, Ginkgo uses the most advanced technology on the planet—biology—to grow better products. The company's cell programming platform is enabling the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. Ginkgo is also actively supporting a number of COVID-19 response efforts, including community testing, epidemiological tracing, vaccine development and therapeutics discovery. For more information, visit www.ginkgobioworks.com.
Ginkgo Bioworks Contact:
[email protected]
FidaLab Contact:
[email protected]
Related Images
image1.jpg
SOURCE FidaLab LLC
As more and more schools work to support in-person learning environments, communities across the country have turned to COVID-19 testing to monitor the virus. Even as teachers and guardians become eligible for vaccines, clinical vaccine trials for individuals under 16 are just beginning, and efforts to track and mitigate viral spread remain critical.
Concentric by Ginkgo's goal is to provide easy, affordable pooled testing to every school in America. Pooled classroom testing, which combines swabs from all consenting individuals in a classroom and runs them as a single test can significantly increase testing capacity and lower the cost of testing programs. Over 800 hundred schools are currently signed up to test with Concentric across the country.
"We are excited at the prospect of joining Ginkgo to provide mass COVID testing in schools to help maintain in-person learning environments in Washington. Ginkgo has proven itself in successfully implementing school testing programs in the State of Massachusetts, Maryland, and beyond. The combination of our local testing capability and Ginkgo's experience and organizational strength will provide a very reliable option for Washington school systems," said Myles Yu, Chief Medical Officer of FidaLab.
More on Washingtoner
- Two Florida Family Law Firms Named Among the State's Best Divorce Practices for 2026
- Tacoma: No Impact to Garbage, Recycling and Yard/Food Waste Pick-Ups on June 19
- Tacoma Arts Live And Accelerating Creative Enterprise Present Ace Showace
- George Martinez Launches Community Re-distribution Initiative With Donation to the Gamma Alpha Alpha Chapter of Omega Psi Phi Fraternity, Inc
- SITE Technologies Releases Industry Research Report Exposing the CapEx Intelligence Gap in Commercial Real Estate
On February 17, 2021, the U.S. Department of Health and Human Services (HHS) in partner with the Department of Defense (DOD) has announced a $650 million investment to expand COVID-19 testing capacity for K-8 schools to support President Biden's plan to re-open schools for in-person learning.
"The funding provided by the Biden Administration will help make it possible for schools in Washington and across the country to engage in pooled testing for every student, every week," said Jason Kelly, CEO and co-founder of Ginkgo Bioworks. "Testing in schools will support the entire community by providing opportunities to limit the spread, and to interrupt chains of transmission."
FidaLab joined the fight against the COVID-19 pandemic at the very beginning and has built massive PCR testing capability for SARS-CoV-2, the virus that causes COVID-19. FidaLab has provided mass testing in collaboration with large scale county testing, schools, long term care facilities, athletic teams and more.
To learn more about Concentric by Ginkgo or to get your school district involved, head over to concentricbyginkgo.com.
About FidaLab
FidaLab is a privately owned CLIA-certified clinical laboratory based in Seattle with a specialty in molecular diagnosis of infectious diseases using cutting edge biotechnologies. With its proven diagnostic accuracy and 24-hour turnaround time, FidaLab has earned the trust of the communities it serves.
More on Washingtoner
- A Business Novel About Ambition, Ethics, and the Hidden Realities of International Business
- Spokane: Upriver Fire – Camp Sekani Update 06/17/26
- Spokane Police Assist Spokane County With The Upriver Fire
- Century Fasteners Corp. Exhibiting at 2026 Farnborough International Airshow
- Compton to host first Juneteenth celebration with We Are Us Festival
About Ginkgo Bioworks
Concentric by Ginkgo is Ginkgo Bioworks' public health and biosecurity effort. Headquartered in Boston, Ginkgo uses the most advanced technology on the planet—biology—to grow better products. The company's cell programming platform is enabling the growth of biotechnology across diverse markets, from food to fragrance to pharmaceuticals. Ginkgo is also actively supporting a number of COVID-19 response efforts, including community testing, epidemiological tracing, vaccine development and therapeutics discovery. For more information, visit www.ginkgobioworks.com.
Ginkgo Bioworks Contact:
[email protected]
FidaLab Contact:
[email protected]
Related Images
image1.jpg
SOURCE FidaLab LLC
0 Comments
Latest on Washingtoner
- Freedomtech Solutions Launches the World's First Pre‑Installed Agentic AI Server — Instant, Sovereign, Infrastructure‑Native Intelligence
- GitKraken Introduces Code Flow, a Framework for Software Development in the Agentic Era
- SanctionsLookup Launches Free OFAC Search Tool for U.S. Sanctions Screening
- RIGHT CARS Announces Landmark African Expansion Through Strategic Collaboration Agreement Across Eight Nations
- Spokane: Housing and Human Services Dept. Provides Update on Housing and Homelessness Initiatives
- Boston Industrial Solutions' Natron® 717N Series UV LED Ink Receives CPSIA Certification
- Spokane City Clerk To Retire After 30 Years In Role, Successor Named
- purelyIV Expands Mobile IV Therapy to Jackson, MI and Launches PlaqueX® IV Therapy
- Leimert Juneteenth Community Celebration Set for Friday, June 19, in Leimert Park Village
- UK Financial Ltd Publishes Maya Preferred Public Proof Package and CoinMarketCap Supply Verification Evidence
- Haven Treatment Center Launches Community Haircut Drive to Help Local Families
- Advancing High-Potential Nevada Critical Minerals Portfolio as Major Drill Program Nears Assay Results: Glenstar Minerals: Stock Symbol: GSTRF
- Allstream Energy Partners to Host 6th Executive Networking After 2026 Energy Projects Conference
- CAPHRA: Australia and Thailand show nicotine prohibition fuels illicit markets
- Custom Disposables - Wholesale Packaging Solutions for restaurants, food chains, and food distributors
- California Security Glass is an affordable bulletproof glass installation company in LA serving a variety of neighboring cities
- Allstream Energy Partners Announce Media Partnership with the 2026 EPC Show - The Energy Projects Conference
- STO Foundation Launching June 29, 2026 to Advance the Global Tokenization Industry
- West Virginia Leaders Announce Support for Election Integrity Network's Model Election Laws Handbook
- Spokane: Chat & Chew District 3 Council Members